Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis

American Journal of Cardiology

Volumn 106, Issue 7, 2010, Pages 1011-1015

  Shiue, Angela B ^a   Stancoven, Amy B ^a   Purcell, Jonathan B ^b   Pinkston, Kristi ^a   Wang, Andrew ^c   Khera, Amit ^a   De Lemos, James A ^a   Peterson, Gail E ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; CENTRAL NERVOUS SYSTEM DISEASE; DEATH; FEMALE; HEART ABSCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; BLOOD; ENDOCARDITIS; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; RISK FACTOR;

ENDOCARDITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TROPONIN I;

EID: 77956988060     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.05.034     Document Type: Article

References (33)

1. L.M. Baddour, W.R. Wilson, A.S. Bayer, V.G. Fowler Jr, A.F. Bolger, M.E. Levison, P. Ferrieri, M.A. Gerber, L.Y. Tani, M.H. Gewitz, D.C. Tong, J.M. Steckelberg, R.S. Baltimore, S.T. Shulman, J.C. Burns, D.A. Falace, J.W. Newburger, T.J. Pallasch, M. Takahashi, and K.A. Taubert Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America Circulation 111 2005 e394 e434
2. Document Reviewers G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, U. Thilen, J. Lekakis, M. Lengyel, L. Muller, C.K. Naber, P. Nihoyannopoulos, A. Moritz, J.L. Zamorano ESC Committee for Practice Guidelines A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, R. Aguilar, M.G. Bongiorni, M. Borger, E. Butchart, N. Danchin, F. Delahaye, R. Erbel, D. Franzen, K. Gould, R. Hall, C. Hassager, K. Kjeldsen, R. McManus, J.M. Miro, A. Mokracek, R. Rosenhek, J.A. San Roman Calvar, P. Seferovic, C. Selton-Suty, M.S. Uva, R. Trinchero, and G. van Camp Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Eur Heart J 30 2009 2369 2413
3. D.R. Murdoch, G.R. Corey, B. Hoen, J.M. Miro, V.G. Fowler Jr, A.S. Bayer, A.W. Karchmer, L. Olaison, P.A. Pappas, P. Moreillon, S.T. Chambers, V.H. Chu, V. Falco, D.J. Holland, P. Jones, J.L. Klein, N.J. Raymond, K.M. Read, M.F. Tripodi, R. Utili, A. Wang, C.W. Woods, C.H. Cabell International Collaboration on Endocarditis-Prospective Cohort Study Investigators Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study Arch Intern Med 169 2009 463 473
4. P. Moreillon, and Y.-A. Que Infective endocarditis Lancet 363 2004 139 149
5. C.H. Cabell, E. Abrutyn, J.V.G. Fowler, B. Hoen, J.M. Miro, G.R. Corey, L. Olaison, P. Pappas, K.J. Anstrom, J.A. Stafford, S. Eykyn, G. Habib, C.A. Mestres, and A. Wang Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database Am Heart J 150 2005 1092 1098
6. B. Hoen, F. Alla, C. Selton-Suty, I. Beguinot, A. Bouvet, S. Briancon, J.-P. Casalta, N. Danchin, F. Delahaye, J. Etienne, V. Le Moing, C. Leport, J.-L. Mainardi, R. Ruimy, F. Vandenesch Association pour l'Etude et la Prevention de l'Endocardite Infectieuse Study Group Changing profile of infective endocarditis: results of a 1-year survey in France JAMA 288 2002 75 81
7. E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.-F. Tripodi, B. Barsic, E. Bouza, C.H. Cabell, A.Id.O. Ramos, V. Fowler Jr, B. Hoen, P. Konecny, A. Moreno, D. Murdoch, P. Pappas, D.J. Sexton, D. Spelman, P. Tattevin, J.M. Miro, J.T.M. van der Meer, R. Utili International Collaboration on Endocarditis Prospective Cohort Study Group Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med 168 2008 2095 2103
8. C.H. Cabell, J.G. Jollis, G.E. Peterson, G.R. Corey, D.J. Anderson, D.J. Sexton, C.W. Woods, L.B. Reller, T. Ryan, and V.G. Fowler Jr Changing patient characteristics and the effect on mortality in endocarditis Arch Intern Med 162 2002 90 94
9. J.B. Purcell, M. Patel, A. Khera, J.A. de Lemos, L.W. Forbess, S. Baker, C.H. Cabell, and G.E. Peterson Relation of troponin elevation to outcome in patients with infective endocarditis Am J Cardiol 101 2008 1479 1481
10. P. Tsenovoy, W.S. Aronow, J. Joseph, and M.S. Kopacz Patients with infective endocarditis and increased cardiac troponin I levels have a higher incidence of in-hospital mortality and valve replacement than those with normal cardiac troponin I levels Cardiology 112 2009 202 204
11. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, and K. Nakao Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
12. Y. Saito, K. Nakao, H. Itoh, T. Yamada, M. Mukoyama, H. Arai, K. Hosoda, G. Shirakami, S.-i. Suga, N. Minamino, K. Kangawa, H. Matsuo, and H. Imura Brain natriuretic peptide is a novel cardiac hormone Biochem Biophys Res Commun 158 1989 360 368
13. M.H. Drazner, and J.A. de Lemos Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise Am Heart J 149 2005 187 189
14. R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, B. Stanek, and R. Pacher B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
15. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. vonScheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
16. D. Logeart, G. Thabut, P. Jourdain, C. Chavelas, P. Beyne, F. Beauvais, E. Bouvier, and A.C. Solal Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J Am Coll Cardiol 43 2004 635 641
17. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, and M. Lopatin Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
18. N. Arakawa, M. Nakamura, H. Aoki, and K. Hiramori Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction J Am Coll Cardiol 27 1996 1656 1661
19. T. Omland, A. Aakvaag, V.V.S. Bonarjee, K. Caidahl, R.T. Lie, D.W.T. Nilsen, J.A. Sundsfjord, and K. Dickstein Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-Terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
20. J.A. de Lemos, D.A. Morrow, J.H. Bentley, T. Omland, M.S. Sabatine, C.H. McCabe, C. Hall, C.P. Cannon, and E. Braunwald The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
21. E. Kandil, J. Burack, A. Sawas, H. Bibawy, A. Schwartzman, M.E. Zenilman, and M.H. Bluth B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock Arch Surg 143 2008 242 246
22. M. Brueckmann, G. Huhle, S. Lang, K.K. Haase, T. Bertsch, C. Weiss, J.J. Kaden, C. Putensen, M. Borggrefe, and U. Hoffmann Prognostic value of plasma n-terminal pro-brain natriuretic peptide in patients with severe sepsis Circulation 112 2005 527 534
23. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, C.M. Gibson, S.A. Murphy, N. Rifai, C. McCabe, E.M. Antman, C.P. Cannon, and E. Braunwald Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760 1763
24. G. Kahveci, F. Bayrak, B. Mutlu, A. Bitigen, T. Karaahmet, K. Sonmez, A. Izgi, M. Degertekin, and Y. Basaran Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis Am J Cardiol 99 2007 1429 1433
25. R.H. Tung, C. Garcia, A.M. Morss, R.M. Pino, M.A. Fifer, B.T. Thompson, K. Lewandrowski, E. Lee-Lewandrowski, and J.L. Januzzi Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock Crit Care Med 32 2004 1643 1647
26. Y. Chen, and C. Li Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis Am J Emerg Med 27 2009 701 706
27. F. Post, L.S. Weilemann, C.-M. Messow, C. Sinning, and T. Munzel B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients Crit Care Med 36 2008 3030 3037
28. J.E. Parrillo, C. Burch, J.H. Shelhamer, M.M. Parker, C. Natanson, and W. Schuette A circulating myocardial depressant substance in humans with septic shock Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance J Clin Invest 76 1985 1539 1553
29. R. Shor, Y. Rozenman, A. Bolshinsky, D. Harpaz, Y. Tilis, Z. Matas, A. Fux, M. Boaz, and A. Halabe BNP in septic patients without systolic myocardial dysfunction Eur J Int Med 17 2006 536 540
30. O. Joulin, P. Petillot, M. Labalette, S. Lancel, and R. Neviere Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction Physiol Res 56 2007 291 297
31. A. Kumar, V. Thota, L. Dee, J. Olson, E. Uretz, and J.E. Parrillo Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum J Exp Med 183 1996 949 958
32. R.W. Watkin, L.V. Harper, A.B. Vernallis, S. Lang, P.A. Lambert, A.M. Ranasinghe, and T.S.J. Elliott Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis J Infect 55 2007 220 225
33. I. Rawczynska-Englert, T. Hryniewiecki, and D. Dzierzanowska Evaluation of serum cytokine concentrations in patients with infective endocarditis J Heart Valve Dis 9 2000 705 709